EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
Go back to EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments| (NASDAQ: EYPT) | Delayed: 4.50 -0.06 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.56 | 52 Week High | $ | |||
| Open | $4.50 | 52 Week Low | $ | |||
| Day High | $4.55 | P/E | N/A | |||
| Day Low | $4.45 | EPS | $ | |||
| Volume | 357,292 | |||||

